Zobrazeno 1 - 10
of 338
pro vyhledávání: '"CARON, H.N."'
Autor:
Verly, I.R.N., van Kuilenburg, A.B.P., Abeling, N.G.G.M., Goorden, S.M.I., Fiocco, M., Vaz, F.M., van Noesel, M.M., Zwaan, C.M., Kaspers, G.J.L., Merks, J.H.M., Caron, H.N., Tytgat, G.A.M.
Publikováno v:
In European Journal of Cancer February 2018 90:102-110
Autor:
Kraal, K.C.J.M., Bleeker, G.M., van Eck-Smit, B.L.F., van Eijkelenburg, N.K.A., Berthold, F., van Noesel, M.M., Caron, H.N., Tytgat, G.A.M.
Publikováno v:
In European Journal of Cancer May 2017 76:188-196
Autor:
Hurkmans, E.G.E., Klumpers, M.J., Dello Russo, C., Witte, W. de, Guchelaar, H.J., Gelderblom, H., Cleton-Jansen, A.M., Vermeulen, S.H., Kaal, S., Graaf, W.T.A. van der, Flucke, U., Gidding, C.E.M., Schreuder, H.W.B., Bont, E.S.J.M. de, Caron, H.N., Gattuso, G., Schiavello, E., Terenziani, M., Massimino, M., McCowage, G., Nagabushan, S., Limaye, A., Rose, V., Catchpoole, D., Jorgensen, A.L., Barton, C., Delaney, L., Hawcutt, D.B., Pirmohamed, M., Pizer, B., Coenen, M.J.H., Loo, D.M.W.M. te
Publikováno v:
Frontiers in Pharmacology, 13
Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab554ae826822b89d939d18c4802aab
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/290144
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/290144
Autor:
Schubert, N.A., Chen, C.Y., Rodríguez, A., Koster, J., Dowless, M., Pfister, S.M., Shields, D.J., Stancato, L.F., Vassal, G., Caron, H.N., van den Boogaard, M.L., Henssen, A.G., Molenaar, J.J.
BACKGROUND: Childhood cancer is still a leading cause of death around the world. To improve outcomes, there is an urgent need for tailored treatment. The systematic evaluation of existing preclinical data can provide an overview of what is known and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::6853450f7c1f9ec570f24939d9437cea
http://edoc.mdc-berlin.de/21697/1/21697oa.pdf
http://edoc.mdc-berlin.de/21697/1/21697oa.pdf
Autor:
Knops, R.R.G *, Hulscher, M.E.J.L., Hermens, R.P.M.G., Hilbink-Smolders, M., Loeffen, J.L., Kollen, W.J.W, Kaspers, G.J.L, Caron, H.N., Kremer, L.C.M
Publikováno v:
In Annals of Oncology July 2012 23(7):1906-1911
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Teepen, J.C., Kremer, L.C., Heiden-van der Loo, M. van der, Tissing, W.J., Pal, H.J. van der, Heuvel-Eibrink, M.M. van den, Loonen, J.J., Louwerens, M., Versluys, B., Dulmen-den Broeder, E. van, Visser, O., Maduro, J.H., Leeuwen, F.E. van, Ronckers, C.M., Bresters, D., Batenburg, L., Veening, M., Huizinga, G., Steeg, L. van der, Jaspers, M., Vries, A. de, Aleman, B.M.P., Caron, H.N., Grootenhuis, M.A., Hartogh, J.G. den, Hollema, N., Neggers, S.J.C.M.M., Postma, A., Ridder-Sluiter, J.G. de, Rutgers, E.J.T., DCOG-LATER Study Grp
Publikováno v:
Cancer causes & control. Springer Netherlands
Cancer Causes & Control, 30, 9, pp. 909-922
Cancer Causes and Control, 30(9), 909. Springer Netherlands
Cancer Causes and Control, 30(9), 909-922. Springer Netherlands
Cancer Causes & Control, 30(9), 909-922. Springer Netherlands
Cancer Causes & Control, 30, 909-922
Teepen, J C, Kremer, L C, van der Heiden-van der Loo, M, Tissing, W J, van der Pal, H J, van den Heuvel-Eibrink, M M, Loonen, J J, Louwerens, M, Versluys, B, van Dulmen-den Broeder, E, Visser, O, Maduro, J H, van Leeuwen, F E, Ronckers, C M & the DCOG-LATER Study Group 2019, ' Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort ', Cancer Causes and Control, vol. 30, no. 9, pp. 909-922 . https://doi.org/10.1007/s10552-019-01204-z
Cancer causes & control, 30(9), 909-922. SPRINGER
Cancer Causes and Control, 30(9), 909-922. SPRINGER
Cancer Causes & Control, 30, 9, pp. 909-922
Cancer Causes and Control, 30(9), 909. Springer Netherlands
Cancer Causes and Control, 30(9), 909-922. Springer Netherlands
Cancer Causes & Control, 30(9), 909-922. Springer Netherlands
Cancer Causes & Control, 30, 909-922
Teepen, J C, Kremer, L C, van der Heiden-van der Loo, M, Tissing, W J, van der Pal, H J, van den Heuvel-Eibrink, M M, Loonen, J J, Louwerens, M, Versluys, B, van Dulmen-den Broeder, E, Visser, O, Maduro, J H, van Leeuwen, F E, Ronckers, C M & the DCOG-LATER Study Group 2019, ' Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort ', Cancer Causes and Control, vol. 30, no. 9, pp. 909-922 . https://doi.org/10.1007/s10552-019-01204-z
Cancer causes & control, 30(9), 909-922. SPRINGER
Cancer Causes and Control, 30(9), 909-922. SPRINGER
PURPOSE: Childhood cancer survivors are at increased risk of developing subsequent malignant neoplasms (SMNs). We compared survival and clinical characteristics of survivors with SMNs (sarcoma, breast cancer, or melanoma) and a population-based sampl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093a364278ecd06200a4e6de4329c2d0
https://pure.eur.nl/en/publications/94f8e789-071e-415f-aad3-136325cedb08
https://pure.eur.nl/en/publications/94f8e789-071e-415f-aad3-136325cedb08
Autor:
Kok, J.L., Teepen, J.C., Leeuwen, F.E. van, Tissing, W.J.E., Neggers, S.J.C.M.M., Pal, H.J. van der, Loonen, J.J., Bresters, D., Versluys, B., Heuvel-Eibrink, M.M. van den, Dulmen-den Broeder, E. van, Heiden-van der Loo, M. van der, Aleman, B.M.P., Daniels, L.A., Haasbeek, C.J.A., Hoeben, B., Janssens, G.O., Maduro, J.H., Oldenburger, F., Rij, C. van, Tersteeg, R.J.H.A., Hauptmann, M., Kremer, L.C.M., Ronckers, C.M., Berg, M.H. van den, Bruggink, A.H., Caron, H.N., Dolsma, W.V., Grootenhuis, M.A., Hartogh, J.G. den, Hollema, N., Jongmans, M.C., Jaspers, M.W.M., Postma, A., Vijver, M.J. van de, DCOG-LATER Study Group
Publikováno v:
Neuro-oncology, 21(3), 392-403. Oxford University Press
Neuro-Oncology, 21(3), 392. Oxford University Press
Neuro-Oncology, 21, 3, pp. 392-403
Kok, J L, Teepen, J C, van Leeuwen, F E, Tissing, W J E, Neggers, S J C M M, van der Pal, H J, Loonen, J J, Bresters, D, Versluys, B, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, van der Heiden-van der Loo, M, Aleman, B M P, Daniels, L A, Haasbeek, C J A, Hoeben, B, Janssens, G O, Maduro, J H, Oldenburger, F, van Rij, C, Tersteeg, R J H A, Hauptmann, M, Kremer, L C M, Ronckers, C C M, van den Berg, M H, Bruggink, A H, Caron, H N, Dolsma, W V, Grootenhuis, M A, den Hartogh, J G, Hollema, N, Jongmans, M C, Jaspers, M W M, Postma, A & van de Vijver, M J 2019, ' Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: Contributions of radiation dose, exposed cranial volume, and age ', Neuro-Oncology, vol. 21, no. 3, pp. 392-403 . https://doi.org/10.1093/neuonc/noy124
Neuro-Oncology, 21(3), 392-403. Oxford University Press
Neuro-Oncology, 21(3), 392-403
Neuro-Oncology, 21, 392-403
Neuro-Oncology, 21(3), 392. Oxford University Press
Neuro-Oncology, 21, 3, pp. 392-403
Kok, J L, Teepen, J C, van Leeuwen, F E, Tissing, W J E, Neggers, S J C M M, van der Pal, H J, Loonen, J J, Bresters, D, Versluys, B, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, van der Heiden-van der Loo, M, Aleman, B M P, Daniels, L A, Haasbeek, C J A, Hoeben, B, Janssens, G O, Maduro, J H, Oldenburger, F, van Rij, C, Tersteeg, R J H A, Hauptmann, M, Kremer, L C M, Ronckers, C C M, van den Berg, M H, Bruggink, A H, Caron, H N, Dolsma, W V, Grootenhuis, M A, den Hartogh, J G, Hollema, N, Jongmans, M C, Jaspers, M W M, Postma, A & van de Vijver, M J 2019, ' Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: Contributions of radiation dose, exposed cranial volume, and age ', Neuro-Oncology, vol. 21, no. 3, pp. 392-403 . https://doi.org/10.1093/neuonc/noy124
Neuro-Oncology, 21(3), 392-403. Oxford University Press
Neuro-Oncology, 21(3), 392-403
Neuro-Oncology, 21, 392-403
BACKGROUND: Pediatric cranial radiotherapy (CrRT) markedly increases risk of meningiomas. We studied meningioma risk factors with emphasis on independent and joint effects of CrRT dose, exposed cranial volume, exposure age, and chemotherapy. METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f39ad26bd6d58d438f72feaab2d6b0
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065808893&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065808893&origin=inward
Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects
Autor:
Jaspers, M.W.M., Van den Bos, C., Heinen, R.C., Bakker, P.J.M., Geenen, M.M., Kremer, L.C., Van Leeuwen, F., Caron, H.N.
Publikováno v:
In International Journal of Medical Informatics 2007 76(4):297-305
Autor:
Schepers, S.A., Sint Nicolaas, S.M., Haverman, L., Wensing, M., Schouten-van Meeteren, A.Y., Veening, M.A., Caron, H.N., Hoogerbrugge, P.M., Kaspers, G.J., Verhaak, C.M., Grootenhuis, M.A.
Publikováno v:
Psycho-Oncology, 26, 951-959
Psycho-Oncology, 26, 7, pp. 951-959
Psycho-Oncology, 26, 7, pp. 951-959
Contains fulltext : 177248.pdf (Publisher’s version ) (Closed access) OBJECTIVE: The KLIK method is an online tool that monitors and discusses electronic patient-reported outcomes (ePROs), which has been shown to enhance outcomes. This study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1cf9728100b7076f8bca5902e7b3e792
https://doi.org/10.1002/pon.4242
https://doi.org/10.1002/pon.4242